A. Rapti

719 total citations
10 papers, 545 citations indexed

About

A. Rapti is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Physiology. According to data from OpenAlex, A. Rapti has authored 10 papers receiving a total of 545 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 4 papers in Oncology and 3 papers in Physiology. Recurrent topics in A. Rapti's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers), Cancer Treatment and Pharmacology (3 papers) and Lung Cancer Research Studies (3 papers). A. Rapti is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers), Cancer Treatment and Pharmacology (3 papers) and Lung Cancer Research Studies (3 papers). A. Rapti collaborates with scholars based in Greece, United States and Czechia. A. Rapti's co-authors include M. Veslemes, Ph. Palamidas, E. Papadakis, Ioannis G. Vlachonikolis, Vassilis Georgoulias, Xanthi Tsiafaki, A. Alexopoulos, Demosthenes Bouros, Maria Dimadi and P. Latsi and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and European Respiratory Journal.

In The Last Decade

A. Rapti

10 papers receiving 518 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Rapti Greece 7 462 257 105 83 38 10 545
Daniel Herchenhorn Brazil 14 395 0.9× 205 0.8× 33 0.3× 70 0.8× 29 0.8× 47 575
Judit Kocsis Hungary 9 79 0.2× 164 0.6× 39 0.4× 87 1.0× 26 0.7× 38 341
Taro Tanabe Japan 12 120 0.3× 312 1.2× 42 0.4× 38 0.5× 51 1.3× 25 478
Hirotaka Ono Japan 8 264 0.6× 449 1.7× 40 0.4× 37 0.4× 13 0.3× 23 601
Amélie Deleporte Belgium 13 117 0.3× 277 1.1× 74 0.7× 52 0.6× 48 1.3× 32 486
Kuninobu Kanai Japan 10 316 0.7× 435 1.7× 82 0.8× 71 0.9× 61 1.6× 24 622
Luigi Ventura Italy 12 311 0.7× 152 0.6× 25 0.2× 48 0.6× 44 1.2× 49 431
Monica Rizzo Italy 11 208 0.5× 199 0.8× 20 0.2× 59 0.7× 28 0.7× 20 487
Prakash Manoharan United Kingdom 13 238 0.5× 344 1.3× 35 0.3× 58 0.7× 45 1.2× 43 594
Ahmed Khalil France 9 103 0.2× 127 0.5× 33 0.3× 43 0.5× 62 1.6× 33 290

Countries citing papers authored by A. Rapti

Since Specialization
Citations

This map shows the geographic impact of A. Rapti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Rapti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Rapti more than expected).

Fields of papers citing papers by A. Rapti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Rapti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Rapti. The network helps show where A. Rapti may publish in the future.

Co-authorship network of co-authors of A. Rapti

This figure shows the co-authorship network connecting the top 25 collaborators of A. Rapti. A scholar is included among the top collaborators of A. Rapti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Rapti. A. Rapti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Poulakou, Garyphallia, Evangelos Dimakakos, Αναστάσιος Κόλλιας, et al.. (2021). Beneficial Effects of Intermediate Dosage of Anticoagulation Treatment on the Prognosis of Hospitalized COVID-19 Patients: The ETHRA Study. In Vivo. 35(1). 653–661. 16 indexed citations
2.
Kishore, Amit, et al.. (2020). Association of TGF-β3 and ANXA11 with pulmonary sarcoidosis in Greek population. Expert Review of Respiratory Medicine. 14(10). 1065–1069. 11 indexed citations
3.
Karakatsani, Anna, Despoina Papakosta, A. Rapti, et al.. (2009). Epidemiology of interstitial lung diseases in Greece. Respiratory Medicine. 103(8). 1122–1129. 145 indexed citations
4.
Kosmas, Christos, et al.. (2009). 9088 Phase III study of Lipoplatin plus Gemcitabine versus Cisplatin plus Gemcitabine in advanced NSCLC; interim analysis. European Journal of Cancer Supplements. 7(2). 531–531. 15 indexed citations
5.
6.
Boulikas, Teni, et al.. (2007). Lipoplatin plus gemcitabine versus cisplatin plus gemcitabine in NSCLC: Preliminary results of a phase III trial. Journal of Clinical Oncology. 25(18_suppl). 18028–18028. 6 indexed citations
7.
Αντωνίου, Κατερίνα, Andrew G. Nicholson, Maria Dimadi, et al.. (2006). Long-term clinical effects of interferon gamma-1b and colchicine in idiopathic pulmonary fibrosis. European Respiratory Journal. 28(3). 496–504. 54 indexed citations
8.
9.
Georgoulias, Vassilis, E. Papadakis, A. Alexopoulos, et al.. (2001). Platinum-based and non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a randomised multicentre trial. The Lancet. 357(9267). 1478–1484. 276 indexed citations
10.
Agelaki, Sofia, E. Papadakis, Xanthi Tsiafaki, et al.. (1999). A phase II study of docetaxel (D) and gemcitabine (G) as second-line treatment in patients (pts) with advanced non-small cell lung cancer (NSCLC). European Journal of Cancer. 35. S256–S256. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniel Herchenhorn Breakdown of academic impact, for papers by Judit Kocsis Breakdown of academic impact, for papers by Taro Tanabe Breakdown of academic impact, for papers by Hirotaka Ono Breakdown of academic impact, for papers by Amélie Deleporte Breakdown of academic impact, for papers by Kuninobu Kanai Breakdown of academic impact, for papers by Luigi Ventura Breakdown of academic impact, for papers by Monica Rizzo Breakdown of academic impact, for papers by Prakash Manoharan Breakdown of academic impact, for papers by Ahmed Khalil
Rankless by CCL
2026